Rebamipide: Evidence base for use in gastroenterology

11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.

Cite

CITATION STYLE

APA

Andreev, D. N., & Maev, I. V. (2021). Rebamipide: Evidence base for use in gastroenterology. Terapevticheskii Arkhiv, 92(12), 97–104. https://doi.org/10.26442/00403660.2020.12.200455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free